The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Open accessAbstract
Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistant immortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are not reliant upon the same mechanisms as those which have been targeted). To address these limitations, an international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broad-spectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspects of relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a wide range of high-priority targets (74 in total) that could be modified to improve patient outcomes. For these targets, corresponding low-toxicity therapeutic approaches were then suggested, many of which were phytochemicals. Proposed actions on each target and all of the approaches were further reviewed for known effects on other hallmark areas and the tumor microenvironment. Potential contrary or procarcinogenic effects were found for 3.9% of the relationships between targets and hallmarks, and mixed evidence of complementary and contrary relationships was found for 7.1%. Approximately 67% of the relationships revealed potentially complementary effects, and the remainder had no known relationship. Among the approaches, 1.1% had contrary, 2.8% had mixed and 62.1% had complementary relationships. These results suggest that a broad-spectrum approach should be feasible from a safety standpoint. This novel approach has potential to be relatively inexpensive, it should help us address stages and types of cancer that lack conventional treatment, and it may reduce relapse risks. A proposed agenda for future research is offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Survival Impact of Integrative Cancer Care in Advanced Metastatic Breast Cancer
Block, K. I., Gyllenhaal, C., Tripathy, D., Freels, S. A., Mead, M. N., Block, P. B., Steinmann, W. C., Newman, R. A., & Shoham, J. (2009) · The Breast Journal · doi:10.1111/j.1524-4741.2009.00739.x · Cited by 23
Self-citationQuality of life in patients with K‐RAS wild‐type colorectal cancer
Ringash, J. G., Au, H., Siu, L. L., Shapiro, J. D., Jonker, D. J., Zalcberg, J. R., Moore, M. J., Strickland, A. H., Kotb, R. R., Jeffery, M., et al. (2013) · Cancer · doi:10.1002/cncr.28410 · Cited by 22
VNP: Interactive Visual Network Pharmacology of Diseases, Targets, and Drugs
Hu, Q., Deng, Z., Tu, W., Yang, X., Meng, Z., Deng, Z., & Liu, J. (2014) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2014.1 · Cited by 21
Self-citationTP53 Aberrations in Chronic Lymphocytic Leukemia
Trbušek, M., & Malčíková, J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-8051-8_5 · Cited by 19
Huang, E., Zhao, Y., Chen, G., Baek, S. J., McEntee, M. F., Minkin, S. C., Biggerstaff, J., & Whelan, J. N. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-68 · Cited by 19
Self-citationKumara, H. M. C. S., Kirchoff, D. D., Naffouje, S. A., Grieco, M. J., Herath, S. A. C., Dujovny, N., Kalady, M. F., Hyman, N., Njoh, L., & Whelan, R. L. (2011) · Surgical Endoscopy · doi:10.1007/s00464-011-1953-1 · Cited by 18
Self-citationToward a Core Nutraceutical Program for Cancer Management
McCarty, M. F., & Block, K. I. (2006) · Integrative Cancer Therapies · doi:10.1177/1534735406288443 · Cited by 18
Self-citationPro-oxidant activity of dietary chemopreventive agents: an under-appreciated anti-cancer property
Azmi, A. S., Sarkar, F. H., & Hadi, S. (2013) · F1000Research · doi:10.12688/f1000research.2-135.v1 · Cited by 18
Self-citationIn Vitro Microbiotic Fermentation Causes an Extensive Metabolite Turnover of Rye Bran Phytochemicals
Hanhineva, K., Aura, A., Rogachev, I., Matero, S., Skov, T., Aharoni, A., Poutanen, K. S., & Mykkänen, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039322 · Cited by 18
Multifocal Angiostatic Therapy: An Update
McCarty, M. F., & Block, K. I. (2005) · Integrative Cancer Therapies · doi:10.1177/1534735405282475 · Cited by 16
Self-citationA Holistic Approach to Study the Effects of Natural Antioxidants on Inflammation and Liver Cancer
Costantini, S., Colonna, G., & Castello, G. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-38007-5_18 · Cited by 13
Integrative Therapies in Cancer: Modulating a Broad Spectrum of Targets for Cancer Management
Block, K. I., Block, P. B., & Gyllenhaal, C. (2015) · Integrative Cancer Therapies · doi:10.1177/1534735414567473 · Cited by 11
Self-citationCarter, J. J., Feingold, D. L., Oh, A., Kirman, I., Wildbrett, P., Stapleton, G., Asi, Z., Fowler, R., Bhagat, G., Huang, E. H., et al. (2006) · Surgical Innovation · doi:10.1177/155335060601300107 · Cited by 9
Self-citationFocus Issue: Networking Cancer Treatment Strategies
Ferrarelli, L. K. (2013) · Science Signaling · doi:10.1126/scisignal.2004723 · Cited by 7
Cited by
Elshafie, H. S., Camele, I., & Mohamed, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043266 · Cited by 439
The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells
Hazafa, A., Rehman, K.-U., Jahan, N., & Jabeen, Z. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2019.1637006 · Cited by 388
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
Yarla, N. S., Bishayee, A., Sethi, G., Reddanna, P., Kalle, A. M., Dhananjaya, B. L., Dowluru, K. S. V. G. K., Chintala, R., & Duddukuri, G. R. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.02.001 · Cited by 364
Self-citationPlant flavonoids in cancer chemoprevention: role in genome stability
George, V. C., Dellaire, G., & Rupasinghe, H. P. V. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.11.007 · Cited by 362
Self-citationMigrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Gandalovičová, A., Rosel, D., Fernandes, M., Veselý, P., Heneberg, P., Čermák, V., Petruželka, L., Kumar, S., Sanz-Moreno, V., & Brábek, J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.008 · Cited by 351
Self-citation
Metadata
- Authors
- Block, K. I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A. R. M. R., Amin, A., Aquilano, K., Arbiser, J., Arreola, A., Arzumanyan, A., Ashraf, S. S., Azmi, A. S., Benencia, F., Bhakta, D., Bilsland, A., Bishayee, A., Blain, S. W., Block, P. B., Boosani, C. S., Carey, T. E., Carnero, A., Carotenuto, M., Casey, S. C., Chakrabarti, M., Chaturvedi, R., Chen, G. Z., Chen, H., Chen, S., Chen, Y. C., Choi, B. K., Ciriolo, M. R., Coley, H. M., Collins, A. R., Connell, M., Crawford, S., Curran, C. S., Dabrosin, C., Damia, G., Dasgupta, S., DeBerardinis, R. J., Decker, W. K., Dhawan, P., Diehl, A. M. E., Dong, J.-T., Dou, Q. P., Drew, J. E., Elkord, E., El-Rayes, B., Feitelson, M. A., Felsher, D. W., Ferguson, L. R., Fimognari, C., Firestone, G. L., Frezza, C., Fujii, H., Fuster, M. M., Generali, D., Georgakilas, A. G., Gieseler, F., Gilbertson, M., Green, M. F., Grue, B., Guha, G., Halicka, D., Helferich, W. G., Heneberg, P., Hentosh, P., Hirschey, M. D., Hofseth, L. J., Holcombe, R. F., Honoki, K., Hsu, H.-Y., Huang, G. S., Jensen, L. D., Jiang, W. G., Jones, L. W., Karpowicz, P. A., Keith, W. N., Kerkar, S. P., Khan, G. N., Khatami, M., Ko, Y. H., Kucuk, O., Kulathinal, R. J., Kumar, N. B., Kwon, B. S., Le, A., Lea, M. A., Lee, H.-Y., Lichtor, T., Lin, L.-T., Locasale, J. W., Lokeshwar, B. L., Longo, V. D., Lyssiotis, C. A., MacKenzie, K. L., Malhotra, M., Marino, M., Martinez-Chantar, M. L., Matheu, A., Maxwell, C., McDonnell, E., Meeker, A. K., Mehrmohamadi, M., Mehta, K., Michelotti, G. A., Mohammad, R. M., Mohammed, S. I., Morre, D. J., Muralidhar, V., Muqbil, I., Murphy, M. P., Nagaraju, G. P., Nahta, R., Niccolai, E., Nowsheen, S., Panis, C., Pantano, F., Parslow, V. R., Pawelec, G., Pedersen, P. L., Poore, B., Poudyal, D., Prakash, S., Prince, M., Raffaghello, L., Rathmell, J. C., Rathmell, W. K., Ray, S. K., Reichrath, J., Rezazadeh, S., Ribatti, D., Ricciardiello, L., Robey, R. B., Rodier, F., Rupasinghe, H. P. V., Russo, G. L., Ryan, E. P., Samadi, A. K., Sanchez-Garcia, I., Sanders, A. J., Santini, D., Sarkar, M., Sasada, T., Saxena, N. K., Shackelford, R. E., Shantha Kumara, H. M. C., Sharma, D., Shin, D. M., Sidransky, D., Siegelin, M. D., Signori, E., Singh, N., Sivanand, S., Sliva, D., Smythe, C., Spagnuolo, C., Stafforini, D. M., Stagg, J., Subbarayan, P. R., Sundin, T., Talib, W. H., Thompson, S. K., Tran, P. T., Ungefroren, H., Vander Heiden, M. G., Venkateswaran, V., Vinay, D. S., Vlachostergios, P. J., Wang, Z., Wellen, K. E., Whelan, R. L., Yang, E. S., Yang, H., Yang, X., Yaswen, P., Yedjou, C., Yin, X., Zhu, J., & Zollo, M.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S276-S304
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2177390620
- Cited by
- 300
- References
- 214
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.